-
Scientists from Johns Hopkins University have genetically engineered an experimental nanobody that targets alpha-synuclein protein clumps thought to be involved in the pathophysiology of Parkinson’s disease
Medical Mythbusting Commentary for August 9, 2022 Source:Parkinson’s research: Experimental nanobody targets toxic proteins Reference:α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice
-
Brushing the tree pollen off our cars in the morning as if it is like snow and allergy sufferers are living it.
Medical Mythbusting Commentary for June 29, 2022 Source:Everyone is complaining about seasonal allergies. What gives?
-
Another study confirms the safety and efficacy of peanut powder to desensitize infants and children with peanut allergy.
Medical Mythbusting Commentary for June 20, 2022 Source:Peanut allergy treatment most effective when started early in infants :Study
-
Small in vitro study suggests two new COVID subvariants may dodge natural immunity response. However whether this translates into worsening clinical outcomes remains unanswered.
Medical Mythbusting Commentary for May 4, 2022 Source:Two new subvariants of COVID appear to dodge natural immunity Reference: Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity
-
Many Canadians continue to choose Benadryl as their first choice for allergy medication despite messaging from Canadian Society of Allergy and Clinical Immunology recommending safer 2nd and 3rd generation antihistamines.
Medical Mythbusting Commentary for April 4, 2022 Source:Many Canadians unaware that Benadryl isn’t recommended as first choice for allergy medication: experts
-
UBC, Université de Sherbrooke, and Cornell University researchers report a new enzyme-blocking compound delivered in a nasal spray that effectively treats delta variant infection in mice. Human trials dependent on securing funding.
Medical Mythbusting Commentary for March 29, 2022 Source:New compound delivered in a nasal spray effectively treats delta variant infection in mice Reference:A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic
-
Thursday catchup: Light and sleep do not mix. How climate change will affect allergy sufferers.
Medical Mythbusting Commentary for March 17, 2022 Source:Allergy season will start much earlier than normal and be far more intense because of climate crisis, study suggests Close the blinds during sleep to protect your health Reference:Projected climate-driven changes in pollen emission season length and magnitude over the continental United States Light exposure during sleep impairs…
-
Catch-up Thursday: Science behind why children fare better with Covid based on innate immunity response but still should be vaccine-protected if possible and the WHO issues update on what is known about BA.2.
Medical Mythbusting Commentary for February 23 and 24, 2022 Source:WALL STREET JOURNAL – The Science Behind Why Children Fare Better With Covid-19Statement on Omicron sublineage BA.2
-
The assumption that having had Omicron confers long-term immunity especially for the unvaccinated is not necessarily a slam-dunk. Infectious disease experts aren’t clear on the answer.
Medical Mythbusting Commentary for January 25, 2022 Source:People Who Have Had Omicron Don’t Necessarily Have COVID Immunity — Here’s Why They Should Stay Cautious